Atara Biotherapeutics (ATRA) Selling, General & Administrative (2013 - 2026)
Atara Biotherapeutics (ATRA) recorded Selling, General & Administrative of $3.81 million in Q2 2026, down 41.4% from $6.51 million a year earlier but up 6.0% from the prior quarter.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Selling, General & Administrative (2013 - 2026) Analysis & Trends
On a TTM basis, Atara Biotherapeutics' Selling, General & Administrative came in at $15.68 million as of Jun 30, 2026, down 58.6% year-over-year; for FY2025, it came in at $26.25 million, down 34.2% from FY2024.
- Annual Selling, General & Administrative has declined for four straight years, with a five-year compound annual growth rate of -16.4% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $39.89 million in FY2024 (-21.7%), $50.91 million in FY2023 (-28.9%), $71.55 million in FY2022 (-9.2%) and $78.8 million in FY2021 (+22.4%).
- Quarterly Selling, General & Administrative has ranged from $3.6 million in Q1 2026 to $21.82 million in Q4 2021 over the past five years.
- On a year-over-year basis, Selling, General & Administrative has declined for five consecutive quarters, with an average decline of 35.3% over the last eight quarters.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 35.1% in Q4 2021, against a decline of 68.7% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.6 million (Q1 2026), $4.28 million (Q4 2025) and $3.99 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Atara Biotherapeutics | 127.78 Mn | 117.88 Mn | 439,000.00 | 3.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.81 Mn |
| Mar 31, 2026 | 3.60 Mn |
| Dec 31, 2025 | 4.28 Mn |
| Sep 30, 2025 | 3.99 Mn |
| Jun 30, 2025 | 6.51 Mn |
| Mar 31, 2025 | 11.48 Mn |
| Dec 31, 2024 | 9.44 Mn |
| Sep 30, 2024 | 10.42 Mn |
| Jun 30, 2024 | 8.91 Mn |
| Mar 31, 2024 | 11.11 Mn |
| Dec 31, 2023 | 11.45 Mn |
| Sep 30, 2023 | 12.25 Mn |
| Jun 30, 2023 | 13.34 Mn |
| Mar 31, 2023 | 13.87 Mn |
| Dec 31, 2022 | 13.25 Mn |
| Sep 30, 2022 | 18.92 Mn |
| Jun 30, 2022 | 18.81 Mn |
| Mar 31, 2022 | 20.57 Mn |
| Dec 31, 2021 | 21.82 Mn |
| Sep 30, 2021 | 19.85 Mn |
API Access
Atara Biotherapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();